Optimal Management of Shivering During Therapeutic Hypothermia After Cardiac Arrest

Logan, Angela; Sangkachand, Prasama; Funk, Marjorie
December 2011
Critical Care Nurse;Dec2011, Vol. 31 Issue 6, pe18
Academic Journal
Both pharmacological and nonpharmacological methods are used to control shivering in therapeutic hypothermia. An evidence-based protocol based on the most current research has been developed for the management of shivering during therapeutic hypothermia. Meperidine is the drug of choice and provides the greatest reduction in the shivering threshold. Other effective pharmacological agents recommended for reducing the threshold include dexmedetomidine, midazolam, fentanyl, and magnesium sulfate. In addition, skin counterwarming techniques, such as use of an air-circulating blanket, are effective nonpharmacological methods for reducing shivering when used in conjunction with medication. As a last resort, neuromuscular blocking agents are considered appropriate therapy for management of refractory shivering.


Related Articles

  • Shivering Management During Therapeutic Temperature Modulation: Nurses' Perspective. Presciutti, Mary; Bader, Mary Kay; Hepburn, Millie // Critical Care Nurse;Feb2012, Vol. 32 Issue 1, p33 

    Therapeutic temperature modulation, which incorporates mild hypothermia and maintenance of normothermia, is being used to manage patients resuscitated after cardiac arrest. Methods of modulating temperature include intravenous infusion of cold fluids and surface or endovascular cooling. During...

  • NIH launches trials to evaluate CPR, drugs after sudden cardiac arrest.  // Cardiology Today;Mar2012, Vol. 15 Issue 3, p8 

    The article reports on the launch by the U.S. National Institutes of Health (NIH) of two multicenter clinical trials that will evaluate treatments for sudden cardiac arrest that occurs out of the hospital.

  • Response: Opioid Therapy for Dyspnea: What We Don't Know Exceeds What We Do Know. Hallenbeck, James // Journal of Palliative Medicine;Jan2013, Vol. 16 Issue 1, p6 

    A response by James Hallenbeck to a letter to the editor about his article “Pathophysiologies of Dyspnea Explained: Why Might Opioids Relieve Dyspnea and Not Hasten Death?” in the July 31, 2012 issue is presented.

  • The hottest & coolest trends in temperature management. Akridge, Jeannie // Healthcare Purchasing News;Dec2008, Vol. 32 Issue 12, p16 

    The article looks at temperature management trends used to produce therapeutic outcomes. Warming methods are used to maintain normothermia in surgical patients and therapeutic cooling is used in cardiac arrest situations. Former Buffalo Bills football player Kevin Everett was injected with cold...

  • Therapeutic hypothermia in the treatment of cardiorespiratory arrest. Fenwick, Rob // Emergency Nurse;Feb2010, Vol. 17 Issue 9, p31 

    Prompt treatment of patients with cardiorespiratory arrest can mean the difference between life and death. This article analyses the use of therapeutic hypothermia and aims to educate practitioners about its advantages and disadvantages as an immediate treatment.

  • A Comparison of Repeated High Doses and Repeated Standard Doses of Epinephrine for Cardiac Arrest Outside the Hospital. Gueugniaud, Pierre-Yves; Mols, Pierre; Goldstein, Patrick; Pham, Emmanuel; Dubien, Pierre-Yves; Deweerdt, Carine; Vergnion, Michel; Petit, Paul; Carli, Pierre // New England Journal of Medicine;11/26/98, Vol. 339 Issue 22, p1595 

    Background: Clinical trials have not shown a benefit of high doses of epinephrine in the management of cardiac arrest. We conducted a prospective, multicenter, randomized study comparing repeated high doses of epinephrine with repeated standard doses in cases of out-of-hospital cardiac arrest....

  • Implantable Defibrillators Reduce Death By 23% in Landmark Heart Failure Trial: NIH Study Indicates Need to More Aggressively Identify and Protect Patients at Risk for SCA.  // Journal of Cardiovascular Management;May/Jun2004, Vol. 15 Issue 3, p28 

    Reports on the results of the clinical trial for the implantable cardioverter-defibrillator therapy in people with heart failure in the U.S. Efficacy of the treatment in preventing sudden cardiac death; Safety profile in terms of general adverse events; Reason behind the underutilization of the...

  • Trends in opioid analgesics consumption, Israel, 2000-2008. Ponizovsky, Alexander; Marom, Eli; Zeldin, Alexander; Cherny, Nathan // European Journal of Clinical Pharmacology;Feb2011, Vol. 67 Issue 2, p165 

    Objective: To describe trends in opioid consumption in Israel (morphine, methadone, oxycodone, pethidine, fentanyl, buprenorphine, codeine, and dextropropoxyphene) over the 9 years, 2000-2008, and to explore explanations for changes in consumption, in amounts and the pattern. Methods: Data for...

  • New trends in the pharmacologic management of cardiac arrest. Grauer, Ken // American Family Physician;2/15/94, Vol. 49 Issue 3, p591 

    Reports on the trends in the pharmacologic management of cardiac arrest. Includes the use of high-dose epinephrine; Additional antifibrillatory therapies; Recommendations for the use of beta-blocking agents.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics